Article ViewAbstractThe Review of Diabetic Studies,2006,3,4,169-177.DOI:10.1900/RDS.2006.3.169Published:February 2007Type:Review Article Authors:Akihisa Imagawa, and Toshiaki Hanafusa Author(s) affiliations:Akihisa Imagawa and Toshiaki Hanafusa First Department of Internal Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan. Abstract:Fulminant type 1 diabetes is a new subtype of type 1 diabetes. The term was established in 2000. It is a syndrome characterized by a markedly rapid and almost complete destruction of pancreatic β-cells. Several lines of evidence suggest that both genetic factors, such as human leukocyte antigen (HLA), and environmental factors, such as viral infection, contribute to the development of this disease. It is also suggested that autoimmune processes contribute less critically to fulminant type 1 diabetes than to classic type 1A diabetes. Based on the findings made to date, both viral infection and the subsequent immune reaction in genetically susceptible individuals cause β-cell destruction and lead to fulminant type 1 diabetes. Keywords:Autoimmunity, Diabetes, Enterovirus, HLA, IdiopathicView:PDF (345.39 KB) PDFClick here to download the PDF file. Images Pancreatic β-cells are markedly reduced in fulminant type 1 diabetes ‹ Diabetes and Alzheimer’s Disease – Is There a Connection? up Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase ›